When a cell divides, each daughter cell inherits a complete set of chromosomes. A sophisticated inhibitory mechanism delays chromosome segregation and cell division until everything is in its place.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
Journal of Hematology & Oncology Open Access 04 April 2012
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Stegmeier, F. et al. Nature 446, 876–880 (2007).
Reddy, S. K., Rape, M., Marganski, W. A. & Kirschner, M. W. Nature 446, 921–925 (2007).
Rieder, C. L., Schultz, A., Cole, R. & Sluder, G. J. Cell Biol. 127, 1301–1310 (1994).
Nasmyth, K. Cell 120, 739–746 (2005).
Li, Y., Gorbea, C., Mahaffey, D., Rechsteiner, M. & Benezra, R. Proc. Natl Acad. Sci. USA 94, 12431–12436 (1997).
Hwang, L. H. et al. Science 279, 1041–1044 (1998).
Kim, S. H., Lin, D. P., Matsumoto, S., Kitazono, A. & Matsumoto, T. Science 279, 1045–1047 (1998).
Peters, J.-M. Nature Rev. Mol. Cell Biol. 7, 644–656 (2006).
Sudakin, V., Chan, G. K. & Yen, T. J. J. Cell Biol. 154, 925–936 (2001).
Luo, X., Tang, Z., Rizo, J. & Yu, H. Mol. Cell 9, 59–71 (2002).
Sironi, L. et al. EMBO J. 21, 2496–2506 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peters, JM. The checkpoint brake relieved. Nature 446, 868–869 (2007). https://doi.org/10.1038/446868a
Published:
Issue Date:
DOI: https://doi.org/10.1038/446868a
This article is cited by
-
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
Journal of Hematology & Oncology (2012)
-
ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1
Oncogene (2010)